Summary
Branhamella catarrhalis strains resistant to commonly used penicillins, and presently isolated, produce a β-lactamase. Most of these enzymes are chromosomally mediated, but a plasmid-mediated β-lactamase has been described (enzyme BRO-1). With reference to isoelectric points, 7 different enzymes have been identified: 6 chromosomally mediated and 1 plasmid-mediated. Nevertheless, they have many common properties, such as being biosynthesised constitutively but with a low level of production. They have a penicillinasetype profile, and are strongly inhibited by clavulanic acid.
Similar content being viewed by others
References
Alvarez S, Jones M, Holtsclaw-Berk S, Guardera J, Berk SL. In vitro susceptibilities and β-lactamase production of 53 clinical isolates of Branhamella catarrhalis. Antimicrobial Agents and Chemotherapy 27: 646–647, 1985
Barthélémy M, Péduzzi J, Labia R. Distinction entre les structures primaires des beta-lactamases TEM-1 et TEM-2. Annales de Microbiologie 136A: 311–321, 1985
Brive, C, Barthélémy M, Bouanchaud DH, Labia R. Microheterogeneity of plasmid-coded beta-lactamases in isoelectric focusing. Annales de Microbiologie (Institut Pasteur) 128B: 309–317, 1977
Brorson JE, Martinell J, Wilske H. Branhamella catarrhalis: antibiotic susceptibility and beta-lactamase production. Journal of Antimicrobial Chemotherapy 7: 208–209, 1981
Buu Hoi-Dang Van A, Brive-Le Bouguennec C, Barthélémy M, Labia R. Novel Beta-lactamase from Branhamella catarrhalis. Annales de Microbiologie 129B: 397–406, 1978
Doern GV, Siebers KG, Hallich LM, Morse SA. Antibiotic susceptibility of beta-lactamase producing strains of Branhamella (Neisseria catarrhalis). Antimicrobial Agents and Chemotherapy 17: 24–29, 1980
Eliasson I, Kamme C. Characterization of the plasmid-mediated beta-lactamases in Branhamella catarrhalis, with special reference to substrate affinity. Journal of Antimicrobial Chemotherapy 15: 139–149, 1985
van Embden JDA, van Klingeren B, Dessen-Kroon M, van Wijngaarden LJ. Penicillinase-producing Neisseria gonorrhoeae in Netherlands: epidemiology and genetic and molecular characterization of their plasmids. Antimicrobial Agents and Chemotherapy 18: 789–797, 1980
Farmer T, Reading C. β-Lactamases of Branhamella catarrhalis and their inhibition by clavulanic acid. Antimicrobial Agents and Chemotherapy 21: 506–508, 1982
Gots JS. The detection of penicillinase. Science 102: 309, 1945
Guibourdenche M, Collatz E, Courvalin P, Barthélémy M, Labia R, Riou JY. Recherche de beta-lactamase chez Neisseria gonorrhoeae par l’adaptation en gel de la méthode iodométrique. Annales de Biologie Clinique 41: 209–211, 1983
Johnsson J, Brorson JE. Influence of beta-lactamase-producing strains of Branhamella catarrhalis and Haemophilus influenzae on certain beta-lactam antibiotics. Journal of Antimicrobial Chemotherapy 12: 269–271, 1983
Kamme C. Evaluation of the in vitro sensitivty of Neisseria catarrhalis to antibiotics with respect to acute otitis media. Scandinavian Journal of Infectious Diseases 2: 117–120, 1970
Kamme C, Vang M, Staahl S. Intrageneric and intergeneric transfer of Branhamella catarrhalis beta-lactamase production. Scandinavian Journal of Infectious Diseases 16: 153–155, 1984
Kovatch AL, Wald ER, Michaels RH. Beta-lactamase-producing Branhamella catarrhalis causing otitis media in children. Journal of Pediatrics 102: 261–264, 1983
Labia, R. Barthélémy M, Masson JM. Multiplicité des beta-lactamases: un problème d’isoenzymes ? Comptes Rendus de l’Académie des Sciences (Paris), (Série D), 283: 1597–1600, 1976
Labia R, Barthélémy M. L’enzymogramme des beta-lactamases: adaptation en gel de la méthode iodométrique. Annales de Microbiologie 130B: 295–304, 1979
Labia R, Barthélémy M, Fabre C, Guionie M, Peduzzi J. Kinetic studies of three R-factor mediated beta-lactamases; in Hamilton-Miller and Smith (Eds) Beta-lactamases, pp. 429–442, Academic Press, London, 1979a
Labia R, Fabre C, Masson JM, Barthélémy M, Heitz M, Pitton JS. Klebsiella pneumonia strains moderately resistant to ampicillin and carbenicillin: characterization of a new beta-lactamase. Journal of Antimicrobial Chemotherapy 5: 375–382, 1979b
Labia R, Barthélémy M, Péduzzi J.: Molecular aspects of beta-lactamase inhibition and inactivation by clavulanic acid. Drugs under Experimental and Clinical Research 11: 765–770, 1985
Le Faou A, Rio A. Branhamella catarrhalis en pathologie infectieuses des voies aériennes. Pathologie et Biologie 33: 2035–2037, 1983
Malmvall BO, Brorson JE, Johnsson J. In vitro sensitivity to penicillin V and beta-lactamase production of Branhamella catarrhalis. Journal of Antimicrobial Chemotherapy 3: 374–375, 1977
Matthew M, Harris AM, Marshall MJ, Ross GW. The use of analytical isoelectric focusing for the detection and identification of beta-lactamases. Journal of general Microbiology 88: 169–178, 1975
Medeiros AA, O’Brien TF. Ampicillin-resistant Haemophilus influenzae type B possessing a TEM-type beta-lactamase but little permeability barrier to ampicillin. Lancet 1: 716–718, 1975
Medeiros AA, Cohenford M, Jacoby GA. Five novel plasmidmediated beta-lactamases. Antimicrobial Agents and Chemotherapy 27: 715–719 1985
Meyers JA, Sanchez D, Elwell LP, Falkow S. Simple agarose gel electrophoretic method for the identification and characterization of plasmid deoxyribonucleic acid. Journal of Bacteriology 127: 1529–1537, 1976
Ninane G, Joly J, Kraytman M, Piot P. Bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis treated with amoxycillin/clavulanic acid. Lancet 2: 257, 1978
Percival A, Corkill JE, Rowlands J, Sykes RB. Pathogenicity of and beta-lactamase production by Branhamella (Neisseria) catarrhalis. Lancet 2: 1175, 1977
Pfister IE, Gallager MV, Potterfield TG, Brown DW. Neisseria catarrhalis bacteremia with meningitis. Journal of American Medical Association 193: 339–401, 1965
Philippon A, Paul G, Barthélémy M, Labia R, Nevot P. Properties of the beta-lactamase (penicillinase) produced by Levinea malonatica. FEMS Microbiol. Letters 8: 191–194, 1980
Piot P, Roberts M. Beta-lactamase production in commensal neisseriaceae. Lancet 1: 619, 1979
Pollock AA, Holzman RS. Neisseria catarrhalis endocarditis. Annals of Internal Medicine 85: 206–207, 1976
Preston DA, Hawley LC. Influence of beta-lactamase production on inoculum effects in dilution tests with ampicillin and selected cephalosporins against Haemophilus influenzae and Branhamella catarrhalis. Abstract 349. Paper presented at the 23rd interscience Conference on Antimicrobial Agents and Chemotherapy, Las Vegas, Nevada, 1983
Simpson IN, Plested SJ. The origin and properties of satellite bands seen in isoelectric focusing. Journal of Antimicrobial Chemotherapy 12: 127–131, 1983
Sitavanc, M. Heitz M, Pitton JS. Apparition à Genève d’une souche de gonocoques productrice de beta-lactamase. Médecine et Hygiène 37: 3877–3878, 1979
Stobberingh EE; Davies BI, van Boven CPA: Branhamella catarrhalis: antibiotic sensitivities and beta-lactamases. Journal of Antimicrobial Chemotherapy 13: 55–64, 1984
Sweeney KG, Verghese A, Needham CA. In vitro susceptibilities of isolates from patients with Branhamella catarrhalis pneumonia compared with those of colonizing strains. Antimicrobial Agents and Chemotherapy 27: 499–502, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Labia, R., Barthelemy, M., Le Bouguennec, C.B. et al. Classification of β-Lactamases from Branhamella catarrhalis in Relation to Penicillinases Produced by Other Bacterial Species. Drugs 31 (Suppl 3), 40–47 (1986). https://doi.org/10.2165/00003495-198600313-00011
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198600313-00011